<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>SULFAMYLON- mafenide acetateÂ creamÂ </strong><br>Mylan Institutional Inc.<br></p></div>
<h1></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_1b769b98-6c27-44db-98fc-c9fbdffd787e"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">SULFAMYLON Cream is a soft, white, nonstaining, water-miscible, anti-infective cream for topical administration to burn <span class="product-label-link" type="condition" conceptid="4029919" conceptname="Wound">wounds</span>.</p>
<p>SULFAMYLON Cream spreads, easily, and can be washed off readily with water. It has a slight acetic odor. Each gram of SULFAMYLON Cream contains mafenide acetate equivalent to 85 mg of the base. The cream vehicle consists of cetyl alcohol, steryl alcohol, cetyl esters wax, polyoxyl 40 stearate, polyoxyl 8 stearate, glycerin, and water, with methylparaben, propylparaben, sodium metabisulfite, and edetate disodium as preservatives.</p>
<p>Chemically, mafenide acetate is Î±-Amino-Ï?-toluenesulfonamide monoacetate and has the following structural formula:</p>
<div class="Figure">
<a name="id264"></a><img alt="Sulfamylon Cream Structural Formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9972db4c-703f-4cbc-915c-ec993bff6fb9&amp;name=db682c78-f67e-409c-99bb-8196229721e3-01.jpg">
</div>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_193ad11b-3445-49b6-9bcf-e19471ca321d"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">SULFAMYLON Cream, applied topically, produces a marked reduction in the bacterial population present in the avascular tissues of second- and third-degree <span class="product-label-link" type="condition" conceptid="4022094" conceptname="Thermal burn">burns</span>. Reduction in bacterial growth after application of SULFAMYLON Cream has also been reported to permit spontaneous healing of deep partial-thickness <span class="product-label-link" type="condition" conceptid="4022094" conceptname="Thermal burn">burns</span>, and thus prevent conversion of burn <span class="product-label-link" type="condition" conceptid="4029919" conceptname="Wound">wounds</span> from partial-thickness to full-thickness. It should be noted, however, that delayed <span class="product-label-link" type="condition" conceptid="4337954" conceptname="Eschar">eschar</span> separation has occurred in some cases.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_0c6f4733-a98a-4cca-8b52-70d6c270b25b"></a><a name="section-2.1"></a><p></p>
<h2>Absorption and Metabolism</h2>
<p class="First">Applied topically, SULFAMYLON Cream diffuses through devascularized areas, is absorbed, and rapidly converted to a metabolite (Ï?-carboxybenzenesulfonamide) which is cleared through the kidneys. SULFAMYLON is active in the presence of pus and serum, and its activity is not altered by changes in the acidity of the environment.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_d70fc466-8bf6-4548-9549-d452ed9afc1e"></a><a name="section-2.2"></a><p></p>
<h2>Antibacterial Activity</h2>
<p class="First">SULFAMYLON exerts bacteriostatic action against many gram-negative and gram-positive organisms, including <span class="Italics">Pseudomonas aeruginosa</span>Â and certain <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of anaerobes.</p>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_a3ec58eb-d6ce-4dcf-9804-6f54bf898cb4"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">SULFAMYLON Cream is a topical agent indicated for adjunctive therapy of patients with second- and third- degree <span class="product-label-link" type="condition" conceptid="4022094" conceptname="Thermal burn">burns</span>.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_df6673be-97a1-4a33-8e7f-cc7c10cd5f99"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">SULFAMYLON is contraindicated in patients who are hypersensitive to it. It is not known whether there is cross sensitivity to other sulfonamides.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="i4i_warnings_id_fb5eae6f-442f-45a4-96f6-45b6f14fcd11"></a><a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Fatal <span class="product-label-link" type="condition" conceptid="435503" conceptname="Hemolytic anemia">hemolytic anemia</span> with <span class="product-label-link" type="condition" conceptid="436093" conceptname="Disseminated intravascular coagulation">disseminated intravascular coagulation</span>, presumably related to a  glucose-6-phosphate dehydrogenase deficiency, has been reported following therapy with SULFAMYLON Cream.</p>
<p>Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthmatic</span> episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthmatic</span> than in nonasthmatic people.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_49e3d6c9-20b3-43ad-a015-15aefed3d930"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First">SULFAMYLON and its metabolite, Ï?-carboxybenzenesulfonamide, inhibit carbonic anhydrase, which may result in <span class="product-label-link" type="condition" conceptid="4245042" conceptname="Metabolic acidosis">metabolic acidosis</span>, usually compensated by <span class="product-label-link" type="condition" conceptid="316814" conceptname="Hyperventilation">hyperventilation</span>. In the presence of <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span>, high blood levels of SULFAMYLON and its metabolite may exaggerate the carbonic anhydrase inhibition. Therefore, close monitoring of acid-base balance is necessary, particularly in patients with extensive second-degree or partial-thickness <span class="product-label-link" type="condition" conceptid="4022094" conceptname="Thermal burn">burns</span> and in those with pulmonary or renal dysfunction. Some burn patients treated with SULFAMYLON Cream have also been reported to manifest an unexplained syndrome of marked <span class="product-label-link" type="condition" conceptid="316814" conceptname="Hyperventilation">hyperventilation</span> with resulting <span class="product-label-link" type="condition" conceptid="4006309" conceptname="Respiratory alkalosis">respiratory alkalosis</span> (slightly alkaline blood pH, low arterial pCO<span class="Sub">2</span>, and decreased total CO<span class="Sub">2</span>); change in arterial pO<span class="Sub">2</span> is variable. The etiology and significance of these findings are unknown.</p>
<p>Mafenide acetate cream should be used with caution in burn patients with <span class="product-label-link" type="condition" conceptid="197320" conceptname="Acute renal failure syndrome">acute renal failure</span>.</p>
<p>SULFAMYLON Cream should be administered with caution to patients with history of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to mafenide. It is not known whether there is cross sensitivity to other sulfonamides.</p>
<p>Fungal colonization in and below <span class="product-label-link" type="condition" conceptid="4337954" conceptname="Eschar">eschar</span> may occur concomitantly with reduction of bacterial growth in the burn <span class="product-label-link" type="condition" conceptid="4029919" conceptname="Wound">wound</span>. However, fungal dissemination through the infected burn <span class="product-label-link" type="condition" conceptid="4029919" conceptname="Wound">wound</span> is rare.</p>
<div class="Section" data-sectionCode="34083-6">
<a name="i4i_carcinogenesis_mutagenesis_fertility_id_77f57847-0283-4c8f-86bf-80d50a2ea0b4"></a><a name="section-6.1"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">No long-term animal studies have been performed to evaluate the drugâ€™s potential in these areas.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_pregnancy_C_id_527ef807-0a4b-4c09-b482-d4a9a3d02d74"></a><a name="section-6.2"></a><p></p>
<h2>Pregnancy Category C</h2>
<p class="First">Animal reproduction studies have not been conducted with SULFAMYLON. It is also not known whether SULFAMYLON can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Therefore, the preparation is not recommended for the treatment of a women of childbearing potential, unless the burned area covers more than 20% of the total body surface, or the need for the therapeutic benefit of SULFAMYLON Cream is, in the physicianâ€™s judgment, greater than the possible risk to the fetus.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="i4i_nursing_mothers_id_3ca4b45c-9910-48e0-a3bd-c15a711ee229"></a><a name="section-6.3"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether mafenide acetate is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reaction in nursing infants from SULFAMYLON, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="i4i_pediatric_use_id_520a176f-9d13-4e35-9778-d4c26d964932"></a><a name="section-6.4"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Same as for adults. (See <a href="#i4i_dosage_admin_id_4bea4135-099f-47d3-8910-d39cdc86b224">DOSAGE AND ADMINISTRATION</a>.)</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_b8cc7bdd-5979-49ae-bc70-128554eda377"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">It is frequently difficult to distinguish between an adverse reaction to SULFAMYLON Cream and the effect of a severe burn. A single case of <span class="product-label-link" type="condition" conceptid="4145241" conceptname="Bone marrow depression">bone marrow depression</span> and a single case of acute attack of <span class="product-label-link" type="condition" conceptid="4305376" conceptname="Porphyria">porphyria</span> have been reported following therapy with SULFAMYLON Cream. Fatal <span class="product-label-link" type="condition" conceptid="435503" conceptname="Hemolytic anemia">hemolytic anemia</span> with <span class="product-label-link" type="condition" conceptid="436093" conceptname="Disseminated intravascular coagulation">disseminated intravascular coagulation</span>, presumably related to a glucose-6-phosphate dehydrogenase deficiency, has been reported following therapy with SULFAMYLON Cream.</p>
<p><span class="Italics">Dermatologic:</span> The most frequently reported reaction was <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> on application or a <span class="product-label-link" type="condition" conceptid="4235891" conceptname="Burning sensation">burning sensation</span>. Rare occurrences are <span class="product-label-link" type="condition" conceptid="4219876" conceptname="Excoriation">excoriation</span> of new skin and <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> of skin.</p>
<p><span class="Italics">Allergic:</span> <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">Rash</span> <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>, facial <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span>, hive, <span class="product-label-link" type="condition" conceptid="443720" conceptname="Blister">blisters</span>, <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>, and <span class="product-label-link" type="condition" conceptid="4302954" conceptname="Disorder characterized by eosinophilia">eosinophilia</span>.</p>
<p><span class="Italics">Respiratory:</span> <span class="product-label-link" type="condition" conceptid="317376" conceptname="Tachypnea">Tachypnea</span> or <span class="product-label-link" type="condition" conceptid="316814" conceptname="Hyperventilation">hyperventilation</span>, decrease in arterial pCO<span class="Sub">2</span>.</p>
<p><span class="Italics">Metabolic:</span> <span class="product-label-link" type="condition" conceptid="435517" conceptname="Acidosis">Acidosis</span>, increase in serum chloride.<br>Accidental ingestion of SULFAMYLON Cream has been reported to cause <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_4bea4135-099f-47d3-8910-d39cdc86b224"></a><a name="section-8"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Prompt institution of appropriate measures for controlling <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">shock</span> and <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> is of prime importance. The burn <span class="product-label-link" type="condition" conceptid="4029919" conceptname="Wound">wounds</span> are then cleansed and debrided, and SULFAMYLON Cream is applied with a sterile gloved hand. Satisfactory results can be achieved with application of the cream once or twice daily, to a thickness of approximately 1/16 inch; thicker application is not recommended. The burned areas should be covered with SULFAMYLON Cream at all times. Therefore, whenever necessary, the cream should be reapplied to any areas from which it has been removed (e.g., by patient activity). The routine of administration can be accomplished in minimal time, since dressings usually are not required, if individual patient demands make them necessary, however, only a thin layer of dressings should be used.</p>
<p>When feasible, the patient should be bathed daily to aid in debridement. A whirlpool bath is particularly helpful, but the patient may be bathed in bed or in a shower.</p>
<p>The duration of therapy with SULFAMYLON Cream depends on each patientâ€™s requirements. Treatment is usually continued until healing is progressing well or until the burn site is ready for grafting. SULFAMYLON Cream should not be withdrawn from the therapeutic regimen while there is the possibility of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span>. However, if allergic manifestations occur during treatment with SULFAMYLON Cream, discontinuation of treatment should be considered.</p>
<p>If <span class="product-label-link" type="condition" conceptid="435517" conceptname="Acidosis">acidosis</span> occurs and becomes difficult to control, particularly in patients with pulmonary dysfunction, discontinuing therapy SULFAMYLON Cream for 24 to 48 hours while continuing fluid therapy may aid in restoring acid-base balance.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_70b14016-a76c-47d2-9ee8-28b277bd8d8b"></a><a name="section-9"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">16 oz. Plastic Jar (453.6 g) - NDC 51079-623-83<br>4 oz. Tube (113.4 g) - NDC 51079-623-82<br>2 oz. Tube (56.7 g) - NDC 51079-623-81</p>
<p>Avoid exposure to excessive heat (temperature above 104Â° F or 40Â° C).</p>
<p><span class="Bold">For External Use Only.</span></p>
<p><span class="Bold">Keep this and all medications out of the reach of children.</span></p>
<p><span class="Bold">Rx only</span></p>
<p><span class="Bold">Mylan Institutional Inc.</span><br>Rockford, IL 61103 U.S.A.</p>
<p>REVISED JULY 2013<br>030.4</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_24b92d5d-38c8-4074-9a72-056bec33292a"></a><a name="section-10"></a><p></p>
<p class="First"><span class="Bold">PRINCIPAL DISPLAY PANEL - 16 oz.</span></p>
<p><span class="Bold">NDC 51079-623-83</span></p>
<p><span class="Bold">16 oz. (453.6 g)</span></p>
<p><span class="Bold">SULFAMYLON<span class="Sup">Â®</span><br>CREAM</span> (<span class="Bold">mafenide acetate <br>cream, USP)</span></p>
<p><span class="Bold">Mylan Institutional Inc.</span><br>Rockford, IL 61103 U.S.A</p>
<p>Rx only</p>
<p>058.5</p>
<p>For dosage and administration, see inside<br>booklet.</p>
<p>Avoid exposure to excessive heat (tempera-<br>tures above 104Â°F or 40Â°C).</p>
<p>Dispense in tight, light-resistant container as<br>defined in the official compendia.</p>
<p>Each gram contains mafenide acetate equi-<br>valent to 85 mg base in a water-miscible<br>cream of cetyl alcohol, stearyl alcohol, cetyl<br>esters wax, polyoxyl 40 stearate, polyoxyl 8<br>stearate, glycerin, and water, with methyl-<br>paraben, propylparaben, sodium metabisul-<br>fite, and edetate disodium as preservatives.</p>
<div class="Figure">
<a name="id447"></a><img alt="SULFAMYLONÂ® Cream (mafenide acetate cream, USP) 16 oz. Container Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9972db4c-703f-4cbc-915c-ec993bff6fb9&amp;name=db682c78-f67e-409c-99bb-8196229721e3-02.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>SULFAMYLONÂ 		
					</strong><br><span class="contentTableReg">mafenide acetate cream</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:51079-623</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>MAFENIDE ACETATE</strong> (MAFENIDE) </td>
<td class="formItem">MAFENIDE</td>
<td class="formItem">85Â mg Â inÂ 1Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CETYL ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STEARYL ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POLYOXYL 40 STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>PEG-8 STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>GLYCERIN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>METHYLPARABEN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>PROPYLPARABEN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM METABISULFITE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>EDETATE DISODIUM</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE (soft white) </td>
<td class="formLabel">Score</td>
<td class="formItem">Â Â Â Â </td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem"></td>
<td class="formLabel">Size</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:51079-623-81</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">56.7 g in 1 TUBE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:51079-623-82</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem"></td>
<td class="formItem">113.4 g in 1 TUBE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:51079-623-83</td>
<td class="formItem">6  in 1 BOX</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem"></td>
<td class="formItem">453.6 g in 1 JAR; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA016763</td>
<td class="formItem">12/08/2006</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Mylan Institutional Inc.
							(039615992)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 7/2013<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>7392612b-4864-4ec8-aeaa-8518dff68cff</div>
<div>Set id: 9972db4c-703f-4cbc-915c-ec993bff6fb9</div>
<div>Version: 7</div>
<div>Effective Time: 20130731</div>
</div>
</div>Â <div class="DistributorName">Mylan Institutional Inc.</div></p>
</body></html>
